1-3 of 3
Thomas Eiermann, MD
Close
Sort by
Journal Articles

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen.

Francis Ayuk, MD, Tatjana Zabelina, MD, Ulrike Bacher, MD, Christine Wolschke, MD, Heinrich Lellek, MD, Thomas Eiermann, MD, Rudolf Erttmann, MD, Nicolaus Kröger, MD, Axel R. Zander, MD
Journal: Blood
Blood (2009) 114 (22): 3393.
https://doi.org/10.1182/blood.V114.22.3393.3393
Published: 2009
Journal Articles

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Eray Goekkurt, MD, Jan Stoehlmacher, MD, Christian Stueber, Christine Wolschke, MD, Tatjana Zabelina, MD, Thomas Eiermann, MD, Thomas Binder, MD, Simona Iacobelli, Axel R. Zander, MD, Nicolaus Kröger, MD
Journal: Blood
Blood (2005) 106 (11): 2730.
https://doi.org/10.1182/blood.V106.11.2730.2730
Published: 2005
Journal Articles

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

Nicolaus Kroeger, MD, Brownen Shaw, MD, Simona Iacobelli, PhD, Tatjana Zabelina, MD, Karl Peggs, MD, Avichai Shimoni, MD, Arnon Nagler, MD, Thomas Binder, MD, PhD, Rainer Schwerdtfeger, MD, Michael Kiehl, MD, Herbert G. Sayer, MD, Francis Ayuk, MD, Thomas Eiermann, MD, PhD, David Marks, MD
Journal: Blood
Blood (2004) 104 (11): 980.
https://doi.org/10.1182/blood.V104.11.980.980
Published: 2004